Skip to content

The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids

The Effect of Epidural Steroid Injections on Glycemic Control in Diabetic Patients According to the Doses of Steroids

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01435707
Enrollment
125
Registered
2011-09-19
Start date
2011-09-30
Completion date
2013-03-31
Last updated
2013-12-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

epidural steroid injection, triamcinolone, fasting blood glucose, diabetes mellitus

Brief summary

There has been no reports of the effect of various kinds of steroid or various dose of steroid which are commonly used in the clinical setting. Previous studies have simply shown that the blood glucose level is elevated in diabetes patients and did not show or suggest the adequate strategy of epidural steroid injection in diabetes patients regarding steroid type, dosage or injection interval. Therefore, the investigators tried to evaluate the effect of different dosage of triamcinolone, which is a commonly used steroid in epidural steroid injection, on the blood glucose level.

Detailed description

It is well known that blood glucose level is elevated in diabetes patients more than non-diabetes patients who underwent the epidural steroid injection. However, there has been no reports of the effect of various kinds of steroid or various dose of steroid which are commonly used in the clinical setting. Previous studies have simply shown that the blood glucose level is elevated in diabetes patients and did not show or suggest the adequate strategy of epidural steroid injection in diabetes patients regarding steroid type, dosage or injection interval. Therefore, the investigators tried to evaluate the effect of different dosage of triamcinolone, which is a commonly used steroid in epidural steroid injection, on the blood glucose level.

Interventions

OTHERepidural steroid injection with Triamcinolone 40mg

epidural steroid injection with Triamcinolone 40mg

OTHERSelective transforaminal epidural block with triamcinolone 20 mg

Selective transforaminal epidural block with triamcinolone 20 mg

OTHERcaudal epidural steroid injection with Triamcinolone 20mg

caudal epidural steroid injection with Triamcinolone 20mg

OTHERSelective transforaminal epidural block with triamcinolone 40 mg

Selective transforaminal epidural block with triamcinolone 40 mg

Sponsors

Samsung Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* subjects who undergo epidural steroid injection (caudal epidural injection or selective transforaminal block) in the pain medicine outpatient clinic * subjects older than 20 yrs.

Exclusion criteria

* ASA (American society of Anesthesiologists class) III or more * severe cardiopulmonary disease or brain disorder * Subjects diagnosed uncontrolled diabetes with complications * subjects undergoing hormone therapy * subjects with active infection * subjects with pregnancy * subjects with recent stress condition such as surgery or trauma * subjects with active neurologic disorder * those with anticoagulation therapy

Design outcomes

Primary

MeasureTime frameDescription
fasting blood glucose levelat 7:00 am of postprocedure day 1before breakfast (fasting state)
fasting blood glucoseat 7:00 am of postprocedure day 14

Secondary

MeasureTime frameDescription
post-prandial glucose level2 hour after dinner at postprandial day 1, 2, 3, 4, 5, 6, 7, 142 hour after dinner
visual analogue scale of subjective painat 7 p.m. of postprocedure day 1, 2, 3, 4, 5, 6, 7, 14at 7:00 am of postprocedure day 5

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 10, 2026